AusCann looks to tighten grip on Latin American medicinal cannabis growth spurt

One of Australia‚Äôs most prominent medical cannabis growth stories AusCann (ASX: AC8) has announced that its Chilean joint venture company DayaCann has signed a non-binding memorandum of understanding (MoU) with Canadian medical cannabis company Khiron Life Sciences (TSXV: KHRN). Incorporated in 2014, AusCann holds the full set of necessary licences to grow and manufacture cannabinoid … Continue reading AusCann looks to tighten grip on Latin American medicinal cannabis growth spurt